FDA Grants IDE Approval to TransMedics, Inc. for the Pilot Phase of the PROCEED Clinical Trial for Its Organ Care System(TM) - the First System to Support Beating Heart Transplant
4/19/2007 12:35:24 PM
ANDOVER, Mass.--(BUSINESS WIRE)--TransMedics, Inc., an emerging medical technology company developing advanced solutions for better, more organ transplant technologies, announced today it has received IDE approval to initiate the pilot phase of the PROCEED multi-center clinical trial in the U.S. for its Organ Care System™. The PROCEED trial will evaluate the safety and performance of the Organ Care System (OCS) for heart transplants in the U.S.
comments powered by